Continued">Continued">Continued">Research news – Children Cancer Hospital Egypt 57357

Research news

Connecting the worlds of metabolomics databases June 15, 2021

Collecting the data is a critical step for any research project to kick off. For biomedical scientists, this means delving into petabytes of data scattered into hundreds of public or private databases.

Paying attention to health practitioners’ fear of the vaccination is a necessity to control the pandemic June 2, 2021

Researchers of the Children’s Cancer Hospital Egypt 57357 cooperate with their counterparts in Alhussien Cancer Center and Faculty of Applied Science.

New insights into the virulence arsenal of a common hospital pathogen May 23, 2021

Researchers from Children’s Cancer Hospital 57357 and The British University in Egypt teamed up on a study revealing new insights on virulence factors of “Enterococcus faecalis”, a common hospital-acquired pathogen.

Brain tumors aggregated waste predict the disease severity February 7, 2021

“Overall, our data support that aggresomes are not only a valuable prognostic marker but might also offer a potential target for CPTs treatment in the future.” El-Naggar says.

A Protein language: deciphering the body-microbiome cross-talk December 2, 2019

A review article recently published in in the Journal of “Proteome Research”, highlights the importance of studying the “Metaprotoeme”—the total proteins produced by the community of microbes in our bodies—in providing a vivid picture of the interaction between body cells and microbiome. Microbiome is a modern term that describes the total microbes that inhabit our … Continued

Mitochondria offers a last resort for the most aggressive of breast cancers December 1, 2019

Collaborative research between Hospital 57357 and Zewail City of Science and Technology highlights the role of mitochondria in fighting breast cancer’s resistance to chemotherapy. The study titled “Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells.”  was recently published in the  Scientific Reports, Journal on Sept, 24, … Continued

Aggresomes: A cellular indicator to predict patients’ outcomes in Pediatric Medulloblastoma November 29, 2019

Screening procedure for the presence of aggresomes could impact treatment protocols in the future In a recent study, a 57357 research team was able to detect the presence of aggresomes (aggregated protein inclusion bodies) in samples of pediatric Medulloblastoma (MB) tumors. This type of malignant brain cancer is the most common in children. The researchers were … Continued